Ownership and insider activity for Stereotaxis, Inc. (STXS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Price
| Price | $1.32 |
| Market Cap | $129M |
| Exchange | AMEX |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-01 | SHAMIR NACHUM | A-Award | 43,103 | |
| 2026-07-01 | Benfer David | A-Award | 43,103 | |
| 2026-07-01 | Levin Ross B | A-Award | 43,103 | |
| 2026-07-01 | Curet Myriam | A-Award | 43,103 | |
| 2026-07-01 | Fischel Nathan | A-Award | 43,103 | |
| 2026-07-01 | Menawat Arun Swarup | A-Award | 43,103 | |
| 2026-04-11 | Peery Kimberly R. | A-Award | 40,000 | $75K |
| 2026-01-02 | Menawat Arun Swarup | A-Award | 46,948 | |
| 2026-01-02 | Benfer David | A-Award | 46,948 | |
| 2026-01-02 | Curet Myriam | A-Award | 46,948 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8.5M | $3.7M | $10.8M | $30.2M | $43.9M | $38.7M | $8.6M | $19.8M | $12.2M | $13.4M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $19.8M | 0 | 0 | 0 |
| Receivables | $4.7M | $4.3M | $5.0M | $5.3M | $3.5M | $5.4M | $5.1M | $3.8M | $3.8M | $10.2M |
| Inventory | $5.4M | $1.1M | $1.2M | $1.8M | $3.3M | $4.4M | $7.9M | $8.4M | $8.3M | $9.6M |
| Total Current Assets | $19.4M | $9.9M | $18.0M | $38.8M | $52.7M | $51.4M | $43.2M | $33.3M | $26.4M | $33.8M |
| Property, Plant & Equipment | $1.1M | $592688 | $343693 | $4.5M | $2.4M | $8.4M | $9.2M | $8.3M | $9.1M | $7.9M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $3.8M | $3.8M |
| Intangible Assets | $436569 | $159470 | 0 | 0 | 0 | 0 | 0 | 0 | $7.4M | $6.4M |
| Total Assets | $21.0M | $10.7M | $18.5M | $43.6M | $55.5M | $61.0M | $53.4M | $41.9M | $46.7M | $52.3M |
| Accounts Payable | $2.6M | $1.7M | $1.7M | $2.1M | $1.6M | $4.2M | $3.3M | $3.2M | $5.7M | $4.8M |
| Short-term Debt | 0 | 0 | 0 | 0 | $1.2M | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $35.7M | $30.1M | $10.2M | $12.2M | $13.6M | $13.3M | $14.3M | $13.2M | $21.6M | $22.4M |
| Long-term Debt | 0 | 0 | 0 | 0 | $973252 | 0 | 0 | 0 | 0 | $4.8M |
| Total Liabilities | $36.5M | $31.3M | $11.2M | $15.1M | $15.2M | $21.6M | $21.5M | $20.0M | $35.3M | $33.5M |
| Retained Earnings | -$471.2M | -$477.1M | -$476.7M | -$481.3M | -$488.0M | -$498.7M | -$517.0M | -$537.7M | -$561.7M | -$583.4M |
| Total Equity | -$15.5M | -$20.6M | $7.3M | $28.5M | $40.2M | $39.4M | $31.9M | $21.9M | $11.4M | $18.7M |
| Total Debt | 0 | 0 | 0 | $4.3M | $4.4M | $6.1M | $5.9M | $5.5M | $6.0M | $5.4M |
| Net Debt | -$8.5M | -$3.7M | -$10.8M | -$25.8M | -$39.5M | -$32.6M | -$22.6M | -$14.3M | -$6.2M | -$8.0M |
| Working Capital | -$16.2M | -$20.3M | $7.8M | $26.7M | $39.1M | $38.1M | $29.0M | $20.0M | $4.8M | $11.5M |
Financial Health
| Debt / Equity | 0.30 |
| Current Ratio | 1.42 |
Profitability
| Return on Equity | -132.62% |
| Return on Invested Capital | -74.49% |
| Return on Assets | -40.16% |
| Gross Margin | 55.57% |
| Operating Margin | -73.02% |
| Net Margin | -74.24% |
Related companies: ARCT · CVRX · HUMA · MDXH · NEO · OSUR · QTRX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of STXS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks